H-Index
79
Scimago Lab
powered by Scopus
JCR
Clarivate
Analytics
16%
Acceptance
Rate
call: +1.631.470.9640
Mon-Fri 10 am - 2 pm EST

Logo



eISSN: 1643-3750

Get your full text copy in PDF

B7-H4 is Predictive of Poor Prognosis in Patients with Gastric Cancer

YongHui Cui, ZhiHan Li

(Department of Gastroenterology, The First People’s Hospital of Shangqiu, Shangqiu, Henan, China (mainland))

Med Sci Monit 2016; 22:4233-4237

DOI: 10.12659/MSM.897781


BACKGROUND: Recently, some studies were performed to evaluate the relevance of B7-H4 and gastric cancer (GC) prognosis. However, the results remained controversial. Therefore, we performed the present meta-analysis.
MATERIAL AND METHODS: We performed a systematic search in PubMed and Web of Science databases. All data were extracted and reviewed from each eligible study independently by 2 investigators. The strength of association between B7-H4 and GC prognosis was assessed by computing odds ratio (OR) with its corresponding 95% confidence interval (CI).
RESULTS: Six studies that evaluated the association between B7-H4 and GC prognosis were included. The results showed a statistically significant association of B7-H4 and GC prognosis (OR=1.63, 95%CI=1.30–2.03). Furthermore, we conducted subgroup analysis based on source of B7-H4; the results from blood (OR=1.71; 95%CI, 1.09–2.68) and tissue (OR=1.60; 95%CI, 1.03–2.07) indicated B7-H4 was significantly associated with poor prognosis.
CONCLUSIONS: This meta-analysis suggests that GC patients with high B7-H4 have poor prognosis.

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
I agree